Subburayan Karthikeyan

658 total citations
7 papers, 550 citations indexed

About

Subburayan Karthikeyan is a scholar working on Molecular Biology, Geriatrics and Gerontology and Oncology. According to data from OpenAlex, Subburayan Karthikeyan has authored 7 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Geriatrics and Gerontology and 2 papers in Oncology. Recurrent topics in Subburayan Karthikeyan's work include Bioactive Compounds and Antitumor Agents (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Subburayan Karthikeyan is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). Subburayan Karthikeyan collaborates with scholars based in India, Australia and Oman. Subburayan Karthikeyan's co-authors include N. Rajendra Prasad, S. L. Hoti, N. Krishnakumar, Rajendran Mahalakshmi, Thamilarasan Manivasagam, Selvaraju Subash, Arokiasamy Justin Thenmozhi, Nady Braidy, Musthafa Mohamed Essa and Gilles J. Guillemin and has published in prestigious journals such as Oncotarget, Oxidative Medicine and Cellular Longevity and Biomedicine & Pharmacotherapy.

In The Last Decade

Subburayan Karthikeyan

7 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Subburayan Karthikeyan India	7	240	104	75	63	62	7	550
Reza Entezari Heravi Iran	7	192 0.8×	67 0.6×	113 1.5×	59 0.9×	42 0.7×	11	567
Asma Ismail Mahmod Jordan	13	294 1.2×	83 0.8×	73 1.0×	59 0.9×	59 1.0×	24	742
Guru R. Valicherla India	19	220 0.9×	83 0.8×	35 0.5×	55 0.9×	76 1.2×	32	662
Nora M. Aborehab Egypt	16	281 1.2×	90 0.9×	86 1.1×	98 1.6×	63 1.0×	40	789
Akhilendra Kumar Maurya India	13	286 1.2×	70 0.7×	102 1.4×	38 0.6×	25 0.4×	27	612
Dominique Vervandier‐Fasseur France	18	284 1.2×	110 1.1×	76 1.0×	77 1.2×	66 1.1×	22	792
Emanuele Salvatore Scarpa Italy	14	244 1.0×	95 0.9×	92 1.2×	63 1.0×	37 0.6×	23	646
Zeinab Nouri Iran	11	227 0.9×	35 0.3×	73 1.0×	54 0.9×	42 0.7×	16	511
Mohd Fahad Ullah India	7	315 1.3×	95 0.9×	149 2.0×	52 0.8×	30 0.5×	8	629
Fatemeh Hajiaghaalipour Malaysia	11	233 1.0×	77 0.7×	137 1.8×	58 0.9×	54 0.9×	16	696

Countries citing papers authored by Subburayan Karthikeyan

Since Specialization

Citations

This map shows the geographic impact of Subburayan Karthikeyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subburayan Karthikeyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subburayan Karthikeyan more than expected).

Fields of papers citing papers by Subburayan Karthikeyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subburayan Karthikeyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subburayan Karthikeyan. The network helps show where Subburayan Karthikeyan may publish in the future.

Co-authorship network of co-authors of Subburayan Karthikeyan

This figure shows the co-authorship network connecting the top 25 collaborators of Subburayan Karthikeyan. A scholar is included among the top collaborators of Subburayan Karthikeyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subburayan Karthikeyan. Subburayan Karthikeyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Karthikeyan, Subburayan, et al.. (2016). Glaucarubinone sensitizes KB cells to paclitaxel by inhibiting ABC transporters via ROS-dependent and p53-mediated activation of apoptotic signaling pathways. Oncotarget. 7(27). 42353–42373. 23 indexed citations

Karthikeyan, Subburayan, S. L. Hoti, & N. Rajendra Prasad. (2015). Resveratrol loaded gelatin nanoparticles synergistically inhibits cell cycle progression and constitutive NF-kappaB activation, and induces apoptosis in non-small cell lung cancer cells. Biomedicine & Pharmacotherapy. 70. 274–282. 81 indexed citations

Karthikeyan, Subburayan & S. L. Hoti. (2015). Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance. Anti-Cancer Agents in Medicinal Chemistry. 15(5). 605–615. 99 indexed citations

Karthikeyan, Subburayan. (2014). Resveratrol Modulates Expression of ABC Transporters in Non-Small Lung Cancer Cells: Molecular Docking and Gene Expression Studies. Journal of Cancer Science & Therapy. 6(12). 12 indexed citations

Tamilselvam, Kuppusamy, Nady Braidy, Thamilarasan Manivasagam, et al.. (2013). Neuroprotective Effects of Hesperidin, a Plant Flavanone, on Rotenone-Induced Oxidative Stress and Apoptosis in a Cellular Model for Parkinson’s Disease. Oxidative Medicine and Cellular Longevity. 2013. 1–11. 148 indexed citations

Karthikeyan, Subburayan, et al.. (2011). Radiosensitizing effect of ferulic acid on human cervical carcinoma cells in vitro. Toxicology in Vitro. 25(7). 1366–1375. 91 indexed citations

Krishnakumar, N., et al.. (2011). Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomedicine & Preventive Nutrition. 1(4). 223–231. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact